Hydroheptin: a water-soluble polyene macrolide. I. Taxonomy, fermentation and isolation

Area of Science:

• Microbiology
• Natural Product Chemistry
• Pharmacology

Background:

• Streptomyces species are prolific producers of diverse bioactive secondary metabolites, including antibiotics.
• The discovery of new antifungal agents is crucial for combating rising fungal infections.
• Macrolide antibiotics, particularly heptaenes, are known for their potent antifungal activity.

Purpose of the Study:

• To isolate and characterize a new heptaene macrolide antifungal antibiotic from a soil Streptomyces isolate.
• To identify the producing microorganism and its co-produced metabolites.
• To develop methods for the fermentation, production, and purification of the novel antibiotic.

Main Methods:

• Microbial isolation and identification of Streptomyces chartreusis IMRU 3962.
• Fermentation optimization for antibiotic production.
• Bioassay development for antifungal activity assessment.
• Solvent extraction and organic acid precipitation for hydroheptin isolation and purification.

Main Results:

• A new heptaene macrolide antifungal antibiotic, designated hydroheptin, was discovered.
• The producing strain, Streptomyces chartreusis IMRU 3962, was identified.
• The antibiotic chartreusin was identified as a co-produced metabolite.
• Effective fermentation and purification procedures for hydroheptin were established, yielding a relatively pure product.

Conclusions:

• Streptomyces chartreusis IMRU 3962 is a source of the novel antifungal antibiotic hydroheptin.
• Hydroheptin represents a promising new candidate for antifungal drug development.
• The developed fermentation and purification methods are suitable for the scalable production of hydroheptin.